Trial NCT01559129

View at ClinicalTrials.gov 
Org. Study IDs: CC-4047-SSC-001
Secondary IDs: 2010-023047-15

Last trial update was posted on 2023-12-01

MeSH Interventions

Pomalidomide

MeSH Conditions

Lung Diseases Lung Diseases, Interstitial Scleroderma, Diffuse Scleroderma, Localized Scleroderma, Systemic Sclerosis

Other Conditions

Interstitial Lung Disease Sclerosis, Systemic Systemic Scleroderma Systemic Sclerosis

Stopping Reasons

Enrollment was stopped early (see limitations and caveats section).

Limitations And Caveats

Based upon interim analysis data, the study did not meet its primary endpoints for subjects who had completed blinded treatment. The IDMC recommended the study be stopped due to lack of efficacy and the sponsor agreed with this recommendation.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID